Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$56,635,500
+$31,253,500 QoQ
Shares Held
2,550,000
+82.1% QoQ
Ownership
1.37%
of shares outstanding
% of Portfolio
2.44%
of 13F equity value
Holder Rank
#20
of 245 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Logos Global Management LP holds $2,282,084,584 across 63 Biotechnology names. DYN ranks #14 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ERAS |
Erasca, Inc.
|
12,150,000 | $222,588,000 | |
| 2 | ABVX |
Abivax S.A.
|
1,024,000 | $136,458,240 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
700,000 | $131,096,000 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
3,000,000 | $111,810,000 | |
| 5 | BNTX |
BioNTech SE
|
1,015,000 | $94,445,750 | |
| 6 | VERA |
Vera Therapeutics, Inc.
|
2,200,000 | $94,402,000 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
2,850,000 | $89,091,000 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
260,000 | $87,045,400 |
All Filings in DYN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,635,500 | 2,550,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,382,000 | 1,400,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,450,000 | 1,250,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $30,360,000 | 2,400,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $18,088,000 | 1,900,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,230,000 | 500,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,602,000 | 450,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,747,200 | 160,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,351,850 | 265,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $49,114,700 | 1,730,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $25,004,000 | 1,880,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,532,800 | 2,180,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $20,025,000 | 1,780,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,584,000 | 1,700,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $24,918,500 | 2,150,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $29,048,976 | 2,287,321 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $19,923,000 | 2,900,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $26,359,538 | 2,734,392 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $38,456,920 | 3,234,392 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $58,778,926 | 3,619,392 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $43,224,407 | 2,054,392 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $49,764,207 | 3,204,392 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $33,692,232 | 1,604,392 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $32,392,674 | 1,604,392 | Shares | Sole | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||